137 related articles for article (PubMed ID: 18219815)
1. Imaging of remyelination and neuronal health.
Erickson BJ
Curr Top Microbiol Immunol; 2008; 318():73-92. PubMed ID: 18219815
[TBL] [Abstract][Full Text] [Related]
2. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Zivadinov R
Neurology; 2007 May; 68(22 Suppl 3):S72-82; discussion S91-6. PubMed ID: 17548573
[TBL] [Abstract][Full Text] [Related]
3. q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study.
Tanikawa M; Nakahara J; Hata J; Suzuki S; Fujiyoshi K; Fujiwara H; Momoshima S; Jinzaki M; Nakamura M; Okano H; Takahashi S; Suzuki N
J Neurol Sci; 2017 Feb; 373():352-357. PubMed ID: 28088313
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging of demyelination and remyelination models.
Pirko I; Johnson AJ
Curr Top Microbiol Immunol; 2008; 318():241-66. PubMed ID: 18219821
[TBL] [Abstract][Full Text] [Related]
5. Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis.
Nakahara J
Adv Exp Med Biol; 2019; 1190():249-256. PubMed ID: 31760648
[TBL] [Abstract][Full Text] [Related]
6. Measuring injury and repair of myelin and neurons in multiple sclerosis.
Arnold DL; Chen J
Ernst Schering Res Found Workshop; 2005; (53):173-86. PubMed ID: 16315614
[TBL] [Abstract][Full Text] [Related]
7. Quantitative magnetic resonance mapping of the myelin bilayer reflects pathology in multiple sclerosis brain tissue.
Baadsvik EL; Weiger M; Froidevaux R; Faigle W; Ineichen BV; Pruessmann KP
Sci Adv; 2023 Aug; 9(32):eadi0611. PubMed ID: 37566661
[TBL] [Abstract][Full Text] [Related]
8. Remyelination in multiple sclerosis.
Brück W; Kuhlmann T; Stadelmann C
J Neurol Sci; 2003 Feb; 206(2):181-5. PubMed ID: 12559508
[TBL] [Abstract][Full Text] [Related]
9. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
Barkhof F; Bruck W; De Groot CJ; Bergers E; Hulshof S; Geurts J; Polman CH; van der Valk P
Arch Neurol; 2003 Aug; 60(8):1073-81. PubMed ID: 12925362
[TBL] [Abstract][Full Text] [Related]
10. Remyelination therapies: a new direction and challenge in multiple sclerosis.
Plemel JR; Liu WQ; Yong VW
Nat Rev Drug Discov; 2017 Sep; 16(9):617-634. PubMed ID: 28685761
[TBL] [Abstract][Full Text] [Related]
11. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
12. Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Mohan H; Friese A; Albrecht S; Krumbholz M; Elliott CL; Arthur A; Menon R; Farina C; Junker A; Stadelmann C; Barnett SC; Huitinga I; Wekerle H; Hohlfeld R; Lassmann H; Kuhlmann T; Linington C; Meinl E
Acta Neuropathol Commun; 2014 Dec; 2():168. PubMed ID: 25589163
[TBL] [Abstract][Full Text] [Related]
13. Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Stankoff B; Jadasz JJ; Hartung HP; Küry P; Zalc B; Lubetzki C
Curr Opin Neurol; 2016 Jun; 29(3):286-92. PubMed ID: 27035897
[TBL] [Abstract][Full Text] [Related]
14. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
15. Remyelination in multiple sclerosis.
Lassmann H; Brück W; Lucchinetti C; Rodriguez M
Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease.
Rodriguez M
J Neuroimmunol; 1992 Oct; 40(2-3):255-63. PubMed ID: 1430155
[TBL] [Abstract][Full Text] [Related]
17. Imaging of remyelination.
Barkhof F
Mult Scler; 1997 Apr; 3(2):129-32. PubMed ID: 9291166
[TBL] [Abstract][Full Text] [Related]
18. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
19. Current status of myelin replacement therapies in multiple sclerosis.
Huang JK; Franklin RJ
Prog Brain Res; 2012; 201():219-31. PubMed ID: 23186717
[TBL] [Abstract][Full Text] [Related]
20. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.
Gass A; Barker GJ; Kidd D; Thorpe JW; MacManus D; Brennan A; Tofts PS; Thompson AJ; McDonald WI; Miller DH
Ann Neurol; 1994 Jul; 36(1):62-7. PubMed ID: 8024264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
